Apomorphine Hydrocloride Injection
Product Images NDC 52817-720

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Apomorphine Hydrocloride (NDC 52817-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Image 01)

Figure 1 (Image 01)
FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
FDA Label Image

Apomorphine Hydrocloride Pen (Image 03)

Apomorphine Hydrocloride Pen (Image 03)
FDA Label Image

Gray Pen Cap (Image 04)

Gray Pen Cap (Image 04)
FDA Label Image

Gray Pen Body (Image 05)

Gray Pen Body (Image 05)
FDA Label Image

Pen Needle Unit (Image 06)

Pen Needle Unit (Image 06)
FDA Label Image

Cartridge (Image 07)

Cartridge (Image 07)
FDA Label Image

Teal Cartridge Holder (Image 08)

Teal Cartridge Holder (Image 08)
FDA Label Image

Image (Image 09)

Image (Image 09)
FDA Label Image

Needle (Image 10)

Needle (Image 10)
This text is not enough to generate a useful description. The text has only two short phrases that are not enough to provide context.*
FDA Label Image

Step 1 (Image 11)

Step 1 (Image 11)
FDA Label Image

Step 2 (Image 12)

Step 2 (Image 12)
FDA Label Image

Step 3 (Image 13)

Step 3 (Image 13)
FDA Label Image

Step 4 (Image 14)

Step 4 (Image 14)
FDA Label Image

Step 5 (Image 15)

Step 5 (Image 15)
FDA Label Image

Step 6 (Image 16)

Step 6 (Image 16)
FDA Label Image

Step 7 (Image 17)

Step 7 (Image 17)
FDA Label Image

Step 8 (Image 18)

Step 8 (Image 18)
FDA Label Image

Step 9 (Image 19)

Step 9 (Image 19)
FDA Label Image

Step 10 (Image 20)

Step 10 (Image 20)
FDA Label Image

Step 11 (Image 21)

Step 11 (Image 21)
FDA Label Image

Step 12 (Image 22)

Step 12 (Image 22)
FDA Label Image

Step 13 (Image 23)

Step 13 (Image 23)
FDA Label Image

Step 14 (Image 24)

Step 14 (Image 24)
FDA Label Image

Step 15 (Image 25)

Step 15 (Image 25)
FDA Label Image

Principal Display Panel (30 mg/3 mL Cartridge Carton)

Principal Display Panel (30 mg/3 mL Cartridge Carton)
This is a description of a medication called Apomorphine Hydrochloride. It is available in a 30 mg/3 mL (10 mg/mL) injection. Each mL of the sterile solution contains 10 mg of apomorphine hydrochloride, USP as apomorphine hydrochloride hemihydrate, which is equivalent to 8.5 mg apomorphine. The medication also contains sodium metabisulfite, NF, and benzyl alcohol, NF in water for an injection in addition, sodium hydroxide, NF and/or hydrochloric acid, NF may also be included. It is recommended to keep this medication at the temperature between 15°C to 30°C (59°F to 86°F). It is advised to keep the medication away from children. The medication should be used in accordance with the enclosed prescribing information. This medication is single-patient-use with a pen injector, it is not for intravenous use. The medication is manufactured by TruPharma, LC, Tampa, FL 33600.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.